BELARUS:in prospect
               November 2010
Belarus Pharmaceutical Market
The access to the pharmaceutical marketplace of any region is always paired with risks,
challenges and political, financial and economical factors specific to each region.
Belarus Facts and Figures                                                                 An increase in the incidence of thyroid cancer has occurred among people who
                                                                                          were young children and adolescents at the time of the accident and lived in the
Belarus is divided into six regions or oblasts. The capital is Minsk, the country’s       most contaminated areas. The accident has had a negative impact on the mental
political, economic, scientific and cultural center. Mr. Alexander Lukashenko has         health of the population, resulting in overuse of alcohol and tobacco.
served as the President of the Republic of Belarus since July 1994.
                                                                                          As of 1 January 2010, 10 690 cases of HIV infection had been registered. The
Health challenges                                                                         average HIV prevalence is 0.2–0.4%. The HIV epidemic is concentrated in injecting
The average life expectancy at birth is 70.4 years, almost 9 years below the average      drug-users (10.7% in 2009) with a slightly growing HIV prevalence among
for the WHO European Region and 3 years higher than the average for the                   commercial sex workers (2.9%) and men that have sex with men (2.1%). The leading
Commonwealth of Independent States (CIS) countries.                                       mode of transmission is shifting from injecting drug use towards heterosexual
Life expectancy is 76.2 years for women and 64.6 years for men.                           intercourse (the ratio of people infected through the heterosexual mode of
                                                                                          transmission has been growing from 57.3% in 2005 to 77.6% in 2009).
The leading causes of death are diseases of the circulatory system; external causes
such as accidents, poisoning, homicide and suicide; and cancer.                           Tuberculosis is an important public health issue; in 2008, there were 52.9 new cases
                                                                                          and 8.7 deaths per 100 000. The spread of drug-resistant strains is a serious
Unhealthy lifestyles are a serious issue. In 2008, 27.5% of the population aged over
                                                                                          concern.
15 years reported smoking regularly and annual per capita alcohol consumption is
estimated to be 11.74 liters, making tobacco and alcohol the most important risk          Infant and maternal mortality rates are quite low: 5.2 per 1000 live births and 2.8
factors in the country. They contribute particularly to premature mortality in males      per 100 000 live births, respectively. These are significantly lower than the
from diseases of the circulatory system (866 deaths per 100 000 population), which        corresponding CIS averages: 12.8 and 27.4.
is higher than the average for the European Region.                                       SMD offers you an overview of the Belarus market, to support your
Mortality in males from external causes of death (injury and poisoning) and lung          knowledge of this market. We provide you the relevant
cancer (242.6 and 69.5 deaths per 100 000, respectively) is also above the European
                                                                                          information about opportunities as well as some threats in order
average. Nearly half of all deaths in motor vehicle accidents are related to alcohol
abuse.                                                                                    to empower you to perform a successful launch, penetration or
Although the birth rate is low, reproductive health is an important public health         development of your pharmaceutical business.
issue; 6.9% of live births are to mothers aged under 20 years. In addition, Belarus
has a high abortion rate: an estimated 391.2 abortions per 1000 live births.              Belarus:in prospect is available at Euros 120.00
Suicide is another problem. The mortality rate from suicide and self-inflicted
injuries is one of the highest in the Region (25.3 deaths per 100 000): nearly twice      To know more about our report or to discuss this topic further please
the Region’s average.                                                                     do not hesitate to contact us
Environmental health is an important issue for Belarus. About 1.5 million                 Tel/Fax: +38 044 206 17 17/18
Belarusians live in areas polluted as a result of the Chernobyl accident in April 1986.   e-mail: office@smd.net.ua
Belarus:in prospect
                                                                                                                                   CIS: Region Features
                                                                                                                                   Economic Development                           5
                                                                                                                                   Pharmaceutical Market: Executive Summary       6
                                                                                                                                   Pharmaceutical Market: Main Features           7
                                                                                                                                   Pharma Market Regional Structure               8
                                                                                                                                   Belarus
                                                                                                                                   At a Glance                                    9
                                                                                                                                   Economic Situation                            10
                                                                                                                                   Healthcare System                             11
                                                                                                                                   Belarus: Pharma Market
                                                                                                                                   Main Features                                 13
                                                                                                                                   Key Data                                      14
                                                                                                                                   Structure and Dynamics                        15
                                                                                                                                   ATC Classes Dynamics (retail segment)         16
                                                                                                                                   ATC Classes Dynamics (original medicines)     17
                                                                                                                                   ATC Classes Dynamics (generic medicines)      18
                                                                                                                                   Leading Companies                             19
                                                                                                                                   Leading Originator Companies                  20
                                                                                                                                   Leading Generic Companies                     21
                                                                                                                                   Leading Companies in Rx segment               22
                                                                                                                                   Leading Companies in OTC segment              23
                                                                                                                                   Distributors                                  24
                                                                                                                                   Pharmacies                                    25
                                                                                                                                   Belarus: Forecast for 2010-2012
                                                                                                                                   Retail Segment                                28




                                                                                                                                                                  Belarus:in prospect
                                                                                                                                                                               © 2010 SMD
                                                                                             All information contained in this publication is copyrighted in the name of SMD (Support in
                                                                                             Market Development), and as such no part of this publication may be reproduced, repackaged,
                                                                                             redistributed, resold in whole or in any part, or used in any form or by any means graphic,
                                                                                             electronic or mechanical, including photocopying, recording, taping, or by information storage
                                                                                             or retrieval, or by any other means, without the express written consent of the publisher.

DISCLAIMER
All information contained in this publication has been researched and compiled from sources believed to be accurate and reliable at the time of publishing. However, SMD
accepts no liability whatsoever for any loss or damage resulting from errors, inaccuracies or omissions affecting any part of the publication. All information is provided
without warranty, and SMD makes no representation of warranty of any kind as to the accuracy or completeness of any information hereto contained.
SMD (Support in Market Development) - is a leading provider of market research,
sales management and forecasting services to the pharmaceutical industry.

Researches of:
· Pharmaceutics establishments' purchase and sale audit
· Hospital establishments' purchase audit
· Second distribution audit                               Ukraine, 03680
· Import medicine analyses                                Bojenko str., 86i, Kiev
· Doctor prescription analyses                            Tel/Fax: +38 044 206 17 17/18
· Ad Hoc research                                         e-mail: office@smd.net.ua
· Analytical services                                     http://www.smd.net.ua



                                BELARUS:in prospect
                                                                          November 2010

Belarus pharmaceutical market 2010

  • 1.
    BELARUS:in prospect November 2010
  • 2.
    Belarus Pharmaceutical Market Theaccess to the pharmaceutical marketplace of any region is always paired with risks, challenges and political, financial and economical factors specific to each region. Belarus Facts and Figures An increase in the incidence of thyroid cancer has occurred among people who were young children and adolescents at the time of the accident and lived in the Belarus is divided into six regions or oblasts. The capital is Minsk, the country’s most contaminated areas. The accident has had a negative impact on the mental political, economic, scientific and cultural center. Mr. Alexander Lukashenko has health of the population, resulting in overuse of alcohol and tobacco. served as the President of the Republic of Belarus since July 1994. As of 1 January 2010, 10 690 cases of HIV infection had been registered. The Health challenges average HIV prevalence is 0.2–0.4%. The HIV epidemic is concentrated in injecting The average life expectancy at birth is 70.4 years, almost 9 years below the average drug-users (10.7% in 2009) with a slightly growing HIV prevalence among for the WHO European Region and 3 years higher than the average for the commercial sex workers (2.9%) and men that have sex with men (2.1%). The leading Commonwealth of Independent States (CIS) countries. mode of transmission is shifting from injecting drug use towards heterosexual Life expectancy is 76.2 years for women and 64.6 years for men. intercourse (the ratio of people infected through the heterosexual mode of transmission has been growing from 57.3% in 2005 to 77.6% in 2009). The leading causes of death are diseases of the circulatory system; external causes such as accidents, poisoning, homicide and suicide; and cancer. Tuberculosis is an important public health issue; in 2008, there were 52.9 new cases and 8.7 deaths per 100 000. The spread of drug-resistant strains is a serious Unhealthy lifestyles are a serious issue. In 2008, 27.5% of the population aged over concern. 15 years reported smoking regularly and annual per capita alcohol consumption is estimated to be 11.74 liters, making tobacco and alcohol the most important risk Infant and maternal mortality rates are quite low: 5.2 per 1000 live births and 2.8 factors in the country. They contribute particularly to premature mortality in males per 100 000 live births, respectively. These are significantly lower than the from diseases of the circulatory system (866 deaths per 100 000 population), which corresponding CIS averages: 12.8 and 27.4. is higher than the average for the European Region. SMD offers you an overview of the Belarus market, to support your Mortality in males from external causes of death (injury and poisoning) and lung knowledge of this market. We provide you the relevant cancer (242.6 and 69.5 deaths per 100 000, respectively) is also above the European information about opportunities as well as some threats in order average. Nearly half of all deaths in motor vehicle accidents are related to alcohol abuse. to empower you to perform a successful launch, penetration or Although the birth rate is low, reproductive health is an important public health development of your pharmaceutical business. issue; 6.9% of live births are to mothers aged under 20 years. In addition, Belarus has a high abortion rate: an estimated 391.2 abortions per 1000 live births. Belarus:in prospect is available at Euros 120.00 Suicide is another problem. The mortality rate from suicide and self-inflicted injuries is one of the highest in the Region (25.3 deaths per 100 000): nearly twice To know more about our report or to discuss this topic further please the Region’s average. do not hesitate to contact us Environmental health is an important issue for Belarus. About 1.5 million Tel/Fax: +38 044 206 17 17/18 Belarusians live in areas polluted as a result of the Chernobyl accident in April 1986. e-mail: office@smd.net.ua
  • 3.
    Belarus:in prospect CIS: Region Features Economic Development 5 Pharmaceutical Market: Executive Summary 6 Pharmaceutical Market: Main Features 7 Pharma Market Regional Structure 8 Belarus At a Glance 9 Economic Situation 10 Healthcare System 11 Belarus: Pharma Market Main Features 13 Key Data 14 Structure and Dynamics 15 ATC Classes Dynamics (retail segment) 16 ATC Classes Dynamics (original medicines) 17 ATC Classes Dynamics (generic medicines) 18 Leading Companies 19 Leading Originator Companies 20 Leading Generic Companies 21 Leading Companies in Rx segment 22 Leading Companies in OTC segment 23 Distributors 24 Pharmacies 25 Belarus: Forecast for 2010-2012 Retail Segment 28 Belarus:in prospect © 2010 SMD All information contained in this publication is copyrighted in the name of SMD (Support in Market Development), and as such no part of this publication may be reproduced, repackaged, redistributed, resold in whole or in any part, or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means, without the express written consent of the publisher. DISCLAIMER All information contained in this publication has been researched and compiled from sources believed to be accurate and reliable at the time of publishing. However, SMD accepts no liability whatsoever for any loss or damage resulting from errors, inaccuracies or omissions affecting any part of the publication. All information is provided without warranty, and SMD makes no representation of warranty of any kind as to the accuracy or completeness of any information hereto contained.
  • 4.
    SMD (Support inMarket Development) - is a leading provider of market research, sales management and forecasting services to the pharmaceutical industry. Researches of: · Pharmaceutics establishments' purchase and sale audit · Hospital establishments' purchase audit · Second distribution audit Ukraine, 03680 · Import medicine analyses Bojenko str., 86i, Kiev · Doctor prescription analyses Tel/Fax: +38 044 206 17 17/18 · Ad Hoc research e-mail: office@smd.net.ua · Analytical services http://www.smd.net.ua BELARUS:in prospect November 2010